Assyro AI

FDA Orange Book · active-ingredient family

Azlocillin sodium

Azlocillin sodium is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:AZLIN · NDA 050562

1

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
AZLIN×3BAYER PHARMSNDA 050562Sep 03, 1982

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
AZLIN×3BAYER PHARMSANDA 062417Oct 12, 1982
AZLIN×3BAYER PHARMSANDA 062388Sep 08, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Azlocillin sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.